FDA.reportPublic FDA data

Application 090498

Type
ANDA
Sponsor
ISTITUTO BIO ITA SPA

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001PIPERACILLIN AND TAZOBACTAMPIPERACILLIN SODIUM; TAZOBACTAM SODIUMINJECTABLE;INJECTIONEQ 36GM BASE/VIAL;EQ 4.5GM BASE/VIALNoNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
44567-804Piperacillin and TazobactamPiperacillin and TazobactamWG Critical Care, LLCANDACurrent
44567-804Piperacillin and TazobactamPiperacillin and TazobactamWG Critical Care, LLCANDACurrent
44567-804Piperacillin and TazobactamPiperacillin and TazobactamWG Critical Care, LLCANDACurrent
44567-804Piperacillin and TazobactamPiperacillin and TazobactamWG Critical Care, LLCANDACurrent
63323-304Piperacillin and TazobactamPiperacillin Sodium and Tazobactam SodiumFresenius Kabi USA, LLCANDACurrent
63323-304Piperacillin and TazobactamPiperacillin Sodium and Tazobactam SodiumFresenius Kabi USA, LLCANDACurrent
63323-304Piperacillin and TazobactamPiperacillin Sodium and Tazobactam SodiumFresenius Kabi USA, LLCANDACurrent
63323-304Piperacillin and TazobactamPiperacillin Sodium and Tazobactam SodiumFresenius Kabi USA, LLCANDACurrent
63323-304Piperacillin and TazobactamPiperacillin Sodium and Tazobactam SodiumFresenius Kabi USA, LLCANDACurrent
63323-304Piperacillin and TazobactamPiperacillin Sodium and Tazobactam SodiumFresenius Kabi USA, LLCANDACurrent
70860-123Piperacillin and Tazobactampiperacillin and tazobactamAthenex Pharmaceutical Division, LLC.ANDACurrent
70860-123Piperacillin and Tazobactampiperacillin and tazobactamAthenex Pharmaceutical Division, LLC.ANDACurrent
70860-123Piperacillin and Tazobactampiperacillin and tazobactamAthenex Pharmaceutical Division, LLC.ANDACurrent